Monday Jun 23, 2025
NEWSLETTER
www.israelhayom.com
  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
Home Science & Technology Startup Nation

Bayer, Tel Aviv University partner to test drugs on 3D-printed human heart tissues

Human heart tissues 3D-printed in Tel Aviv University's Laboratory for Tissue Engineering and Regenerative Medicine will be used to test the cardiotoxicity of experimental drugs as part of a collaboration between the university's tech-transfer company, Ramot, and the German pharmaceutical giant.

by  ILH Staff
Published on  07-09-2020 10:30
Last modified: 07-26-2020 10:21
Bayer, Tel Aviv University partner to test drugs on 3D-printed human heart tissuesCourtesy of Bayer

View of the first 3D-printed vascularized engineered heart in Prof. Tal Dvir’s laboratory in the Tel Aviv University | Photo: Courtesy of Bayer

Share on FacebookShare on Twitter

Human heart tissues were 3D-printed at Prof. Tal Dvir's Laboratory for Tissue Engineering and Regenerative Medicine at Tel Aviv University. These will be used to test the cardiotoxicity of experimental drugs as part of a collaboration between the university's tech-transfer company, Ramot, and German pharmaceutical giant Bayer.

"We are excited to start this new collaboration with Tel Aviv University, which will address a new area of early assessment of safety and tolerability of drug candidates," said Eckhard von Keutz, head of Translational Sciences at Bayer.

Follow Israel Hayom on Facebook and Twitter

"We already have a global network of partners and this new project will enable Bayer to expand its open innovation activities to Israel, which provides a dynamic ecosystem for innovation in biotech and medical research."

Video: Courtesy of Tel Aviv University

Last April, Dvir's lab successfully produced the first-ever 3D-printed heart using tissue extracted from a patient.

This type of innovative technology could potentially revolutionize drug screening.

Drug candidates go through several stages of screening: First, the new compound is tested on human tissue cultures in Petri dishes. Next, it is administered to lab animals, then, the drug is approved for human clinical trials.

Dvir's 3D-printed tissues could make the process faster, cheaper, and more efficient, the university said.

"In a Petri dish, all the cells line up in 2D, and it's only one type of cell," Dvir said. "In contrast, our engineered tissues are 3D-printed, and therefore better resemble real heart tissues. Our printed tissues contain cardiac muscle, blood vessels, and the extracellular matrix which connects the different cells biochemically, mechanically, and electrically. Moving away from Petri dishes to 3D printed tissues could significantly improve drug tests, saving precious time and money with the hope of producing safer and more effective medication."

Dvir hopes to eventually offer Bayer the ability to do pre-clinical trials on complete printed organs.

"Our end goal is to engineer whole human hearts, including all the different chambers, valves, arteries, and veins – the best analog of this complex organ – for an even better toxicological screening process," he explained.

According to a press release by Bayer, Ramot licensed the technology to a spin-off company, Matricelf, whose first focus is on engineering personalized spinal-cord implants to treat paralyzed patients.

Subscribe to Israel Hayom's daily newsletter and never miss our top stories!

Tags: 3D printingtesting

Related Posts

OpenAI's Sora Turbo transforms text into instant video contentjacquesdurocher/Getty Images/iStockphoto

A secret AI startup in Tel Aviv got $30B: This Israeli-raised pioneer did it

by Erez Linn

Ilya Sutskever, who gained prominence as chief scientist at OpenAI where he helped develop the technology behind ChatGPT, departed the...

Data operations startup Matia secures $10.5M to streamline enterprise data managementCourtesy of Matia

Data operations startup Matia secures $10.5M to streamline enterprise data management

by Erez Linn

The Israeli founders secure $10.5M to streamline enterprise data management as part of the AI revolution.

Arieli EL acquires 59.1% stake in Elron Ventures for $53.2MGetty Images/iStockphoto

Arieli EL acquires 59.1% stake in Elron Ventures for $53.2M

by ILH Staff

Arieli EL, part of the Arieli group of companies, has announced the acquisition of a 59.1% stake in veteran cyber...

Menu

Analysis 

Archaeology

Blogpost

Business & Finance

Culture

Exclusive

Explainer

Environment

 

Features

Health

In Brief

Jewish World

Judea and Samaria

Lifestyle

Cyber & Internet

Sports

 

Diplomacy 

Iran & The Gulf

Gaza Strip

Politics

Shopping

Terms of use

Privacy Policy

Submissions

Contact Us

About Us

The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.

All rights reserved to Israel Hayom

Hosted by sPD.co.il

  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il

Newsletter

[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]

  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il